Mutations That Permit Efficient Replication of Hepatitis C Virus RNA in Huh-7 Cells Prevent Productive Replication in Chimpanzees

The development of a subgenomic replicon derived from the hepatitis C virus (HCV) strain Con1 enabled the study of viral RNA replication in Huh-7 cells. The level of replication of replicons, as well as full-length Con1 genomes, increased significantly by a combination of two adaptive mutations in N...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 99; no. 22; pp. 14416 - 14421
Main Authors Bukh, Jens, Pietschmann, Thomas, Lohmann, Volker, Krieger, Nicole, Faulk, Kristina, Engle, Ronald E., Govindarajan, Sugantha, Shapiro, Max, St. Claire, Marisa, Bartenschlager, Ralf
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 29.10.2002
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The development of a subgenomic replicon derived from the hepatitis C virus (HCV) strain Con1 enabled the study of viral RNA replication in Huh-7 cells. The level of replication of replicons, as well as full-length Con1 genomes, increased significantly by a combination of two adaptive mutations in NS3 (E1202G and T1280I) and a single mutation in NS5A (S2197P). However, these cell culture-adaptive mutations influenced in vivo infectivity. After intrahepatic transfection of chimpanzees, the wild-type Con1 genome was infectious and produced viral titers similar to those produced by other infectious HCV clones. Repeated independent transfections with RNA transcripts of a Con1 genome containing the three adaptive mutations failed to achieve active HCV infection. Furthermore, although a chimpanzee transfected with RNA transcripts of a Con1 genome with only the NS5A mutation became infected, this mutation was detected only in virus genomes recovered from serum at day 4; viruses recovered at day 7 had a reversion back to the original Con1 sequence. Our study demonstrates that mutations that are adaptive for replication of HCV in cell culture may be highly attenuating in vivo.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
To whom correspondence should be addressed. E-mail: jbukh@niaid.nih.gov.
Communicated by Robert H. Purcell, National Institutes of Health, Bethesda, MD
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.212532699